Quality Investor

Globus Medical, Inc.

Rank #164Op. Leverage

GMED · NYSE · Healthcare

Globus Medical, Inc. (GMED) — Rank #164 by gross profitability (GP/assets 0.36) · ROE 11.3% · Piotroski F-Score 8 / 9.

As-of 2026-09-15 · CIK 0001237831 · all metrics point-in-time as of the filing date.

About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Show more

The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc.

was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Industry
Medical Devices
Sector
Healthcare
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
December 31

Financials

Weakening

Direction over 5 fiscal years

  • Free cash flowimproving
  • Gross margindeteriorating
  • Gross profitabilitydeteriorating
  • Net cashdeteriorating
  • Operating margindeteriorating
  • Return on equitystable
  • Share count (dilution)deteriorating

Monitoring diagnostic of business direction — not a prediction of returns.

Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.

USD in millions, except per-share (EPS) and percentage rows. Values are as originally filed; em-dash = not tagged in that year's filing.
Fiscal year end2025-12-31filed 2026-02-242024-12-31filed 2025-02-202023-12-31filed 2024-02-212022-12-31filed 2023-02-21
Income statement
EPS growth (YoY)422.7%-29.9%-42.2%
Cash flow

Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?